Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
13.10
+0.20 (1.55%)
At close: May 19, 2026, 4:00 PM EDT
13.32
+0.22 (1.68%)
After-hours: May 19, 2026, 7:38 PM EDT

Olema Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
52.5548.3139.4868.5423.713.81
Short-Term Investments
452.8457.14294.61193.27180.72273.44
Cash & Short-Term Investments
505.35505.44434.09261.81204.42287.25
Cash Growth
28.68%16.44%65.80%28.07%-28.84%-15.15%
Other Current Assets
7.8810.024.394.714.483.44
Total Current Assets
513.23515.45438.47266.51208.9290.69
Net Property, Plant & Equipment
17.4217.9812.5110.436.755.26
Total Assets
530.65533.43450.98276.95215.65295.95
Accounts Payable
3.729.254.462.70.370.02
Accrued Expenses
42.4941.4336.1317.9415.168.07
Current Portion of Leases
0.961.121.170.991.020.93
Total Current Liabilities
47.1751.841.7621.6216.559.02
Long-Term Debt
33----
Long-Term Leases
-0.070.261.431.552.36
Total Long-Term Liabilities
33.070.261.431.552.36
Total Liabilities
50.1754.8742.0223.0518.111.38
Common Stock
0.010.010.01000
Additional Paid-in Capital
1,1321,075843.92559.18408.33388.9
Accumulated Other Comprehensive Income
-0.460.620.140.35-1.81-0.15
Retained Earnings
-650.65-597.56-435.11-305.63-208.98-104.19
Shareholders' Equity
480.48478.56408.96253.9197.55284.57
Total Liabilities & Equity
530.65533.43450.98276.95215.65295.95
Total Debt
3.964.191.432.422.573.29
Net Cash (Debt)
501.39501.24432.66259.39201.86283.96
Net Cash Growth
0.03%15.85%66.80%28.50%-28.91%-16.12%
Net Cash Per Share
5.495.767.375.735.057.18
Book Value
480.48478.56408.96253.9197.55284.57
Book Value Per Share
5.265.506.965.614.947.20
Tangible Book Value
480.48478.56408.96253.9197.55284.57
Tangible Book Value Per Share
5.265.506.965.614.947.20
Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q